C
Contact
Name:
MARCH 2020 | EYEWORLD | 45
lens in patients who have moderate dry eye disease and are
not excited about committing to long-term management
are the ones coming back, and they have more fluctuations
and quality of vision issues postop," Dr. Yeu said.
In addition to preop treatment, Dr. Yeu forms a
"social contract" with patients with well-managed dry eye
disease that they will maintain postop, which may include
getting lid hygiene interventional therapy in the clinic or
prescription anti-inflammatory drops.
"If they are not willing, I won't use a presbyopia-cor-
recting lens," Dr. Yeu said.
Dysphotopsia profile
Dr. Clinch has found EDOF IOL recipients often have
mild to moderate glare, halos, or spiderwebs in the first
1–3 months. Although such dysphotopsias are usually mild
and well tolerated, the symptoms can be exacerbated by
uncorrected refractive error. In patients with substantial
symptomatology (less than 1% of his patients), correction
of the refractive error often reduces the symptoms.
The challenge can be complicated in cases where
the capsule cannot be polished sufficiently in the initial
surgery.
"It is hard to determine how much symptoms are
from the diffractive IOL alone vs. the impact of PCO on
the IOL," Dr. Clinch said. "It is simpler when PCO devel-
ops months or years later."
Dysphotopsias with PanOptix are very different, Dr.
Yeu has found.
"There are no starbursts but maybe some glare," Dr.
Yeu said. "If anything, it will be a ring-like halo around
light. I do not think it is a severe halo from my experience
so far."
SPEAKERS
Dimitri Azar
University of Illinois, Alphabet Verily Sciences
Roger Beuerman
Singapore Eye Research Institute
Wiley Chambers
FDA
Malvina Eydelman
FDA
Steve Fliesler
SUNY Bu• alo, Past President of ARVO
Monica Jablonski
UTHSC Professor of Ophthalmology
Herbert Kaufman
LSU Professor Emeritus
Linda Lam
USC Eye Institute Arcadia
Maureen Maguire
University of Pennsylvania, Director of Center
for Preventive Ophthalmology and Biostatistics
Gerrit R.J. Melles
Netherlands Institute for Innovative Ocular Surgery
Steve Thomas
Heidelberg Engineering, Inc.
Robert Williams
UTHSC Chair of Genetics
Hosted by Penny Asbell, MD
April 3-4 | Memphis, TN
Register at:
utconferences.eventsair.com/vision-2020/
registration/Site/Register.
For more information, call 901.448.1911.
